Genetic Epidemiology of Causal Variants Across the Life Course
Genetic Epidemiology of Causal Variants Across the Life Course
批准号:
8112748
负责人:
Kari E. North
金额:
$177.74万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-17 至 2014-05-31
关键词:
AdultAgeArchitectureAtherosclerosisBehavioralBioinformaticsBiological AssayCardiovascular systemChildhoodChronic DiseaseClinicalCohort StudiesCollaborationsCommunitiesComplexCoronary arteryDNADNA ResequencingDataData AggregationData AnalysesDevelopmentDiseaseDisease OutcomeDrug FormulationsEconomicsEpidemiologyEthnic OriginEthnic groupEvaluationFamily StudyFundingGenderGenesGeneticGenomicsGenotypeGoalsHealthHealth SciencesHeartHispanicsHuman GeneticsIndividualLaboratoriesLifeLife Cycle StagesLiteratureMeasurementMeta-AnalysisMethodsNational Health and Nutrition Examination SurveyNatural HistoryOutcomeParentsPhenotypePopulationPopulation GroupPopulation HeterogeneityPrevalenceProbability SamplesProcessProductivityPublic HealthPublicationsRaceReportingResearch PersonnelResourcesRiskRisk FactorsRoleSamplingSocial ChangeSpecific qualifier valueSubgroupTechniquesTexasTimeTranslational ResearchUniversitiesVariantWomanbaseburden of illnesscohortcommunity burdencommunity health studydata formatdata managementdesignfollow-upgene functiongenetic epidemiologygenetic variantinnovationknowledge basemembermenpopulation basedportabilityprogramspublic health relevanceresponsetraitworking groupyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Genetic Epidemiology of Causal Variants Across the Life Course is submitted in response to RFA HG-07-014, as a consortium of well characterized population based studies and a central genotyping and resequencing core laboratory, to accelerate the understanding of the role and population impact of putative causal genetic variants related to complex diseases. This collaborative network includes six of the most informative and demographically diverse population-based studies extant, contributing approximately 58,000 men and women from the main ethnic and racial groups in the U.S., ranging in age from childhood to old adulthood. Those examined in the six studies are extensively characterized for a wide range of phenotypes and traits, and five studies have immediately available stored DNA of high quality for transfer to the core laboratory.
The participating studies include population based cohorts with repeat examinations and long term follow up and a national probability sample, with clinical and subclinical measurements on a range of health conditions, their precursors and natural history, characterized across the life course. This collaborative network is designed to provide optimal capabilities to estimate and replicate associations of genetic variants with complex diseases in diverse U.S. populations, in individual and environmental contexts of public health relevance, with power sufficient to identify associations, interactions, and population impact in subgroups.
The team of investigators contributes epidemiologic, genetic, methodologic and subject-matter expertise and a demonstrated record of productivity in collaborative, interdisciplinary settings. The network builds on existing capabilities and the proven administrative channels of the assembled partner studies for efficient and timely access to phenotypic, exposure and contextual data, for analyses within each partner study and for replication across studies, and for rapid sharing of the resulting descriptive and association data. The investigators will serve as effective collaborators within the wider study, contributing methodologic innovation and analytic support and serving on committees and working groups set up by the Steering Committee.
The collaborative resource assembled in this application will permit the estimation of the role and population impact of selected genetic variants in diversity-based populations, for an array of chronic diseases, their risk factors and intermediate outcomes, at different life epochs, and for groups defined by potentially modifiable contexts. Genomic assays will be conducted as needed to further characterize the reported associations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic Epidemiology of Causal Variants across the Life Course Phase II (CALiCo I
-
批准号:8573122
-
项目类别:
-
资助金额:$83.28万
-
财政年份:2013
-
负责人:Kari E. North
-
依托单位:
Genetic Epidemiology of Causal Variants across the Life Course Phase II (CALiCo I
-
批准号:8728992
-
项目类别:
-
资助金额:$74.54万
-
财政年份:2013
-
负责人:Kari E. North
-
依托单位:
Genetic Epidemiology of Causal Variants across the Life Course Phase II (CALiCo I
-
批准号:9115214
-
项目类别:
-
资助金额:$76.45万
-
财政年份:2013
-
负责人:Kari E. North
-
依托单位:
Genetic Epidemiology of Causal Variants Across the Life Course
-
批准号:8443562
-
项目类别:
-
资助金额:$98.03万
-
财政年份:2008
-
负责人:Kari E. North
-
依托单位:
Comprehensive Mapping of a Blood Pressure QTL on Chromosome 17
-
批准号:7464874
-
项目类别:
-
资助金额:$69.36万
-
财政年份:2008
-
负责人:Kari E. North
-
依托单位:
Comprehensive Mapping of a Blood Pressure QTL on Chromosome 17
-
批准号:7932748
-
项目类别:
-
资助金额:$72.99万
-
财政年份:2008
-
负责人:Kari E. North
-
依托单位:
Comprehensive Mapping of a Blood Pressure QTL on Chromosome 17
-
批准号:7678016
-
项目类别:
-
资助金额:$70.44万
-
财政年份:2008
-
负责人:Kari E. North
-
依托单位:
Gene-by-Smoking Interaction and Risk of Atherosclerosis
-
批准号:6905581
-
项目类别:
-
资助金额:$28.5万
-
财政年份:2003
-
负责人:Kari E. North
-
依托单位:
Gene-by-Smoking Interaction and Risk of Atherosclerosis
-
批准号:6676760
-
项目类别:
-
资助金额:$38.05万
-
财政年份:2003
-
负责人:Kari E. North
-
依托单位:
Gene-by-Smoking Interaction and Risk of Atherosclerosis
-
批准号:6760157
-
项目类别:
-
资助金额:$42.61万
-
财政年份:2003
-
负责人:Kari E. North
-
依托单位:
HYPERGEN-NC
-
批准号:6777563
-
项目类别:
-
资助金额:$8.45万
-
财政年份:1995
-
负责人:Kari E. North
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: